Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CHRS
#3586
Coherus Oncology, Inc. - Common Stock
1.3
6
USD
-0.04%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-4.23%
Monthly Change
-6.85%
6 month change
-19.05%
Year Change
-15.53%
Previous Close
1.4
2
Open
1.3
6
Low
1.3
6
High
1.3
6
Volume
31
Markets
US Stock Market
Healthcare
Biotechnology
CHRS
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
2024
Quarterly report, Q2 FY2024
2024.08.08
Coherus Oncology, Inc. quarterly report, Q2 FY2024
10-Q
Current report, Q2 FY2024
2024.07.02
Coherus Oncology, Inc. current report, Q2 FY2024
8-K
Current report, Q2 FY2024
2024.06.27
Coherus Oncology, Inc. current report, Q2 FY2024
8-K
1
2
3
4
5
News
Coherus: 'Hold' On Several 2026 Catalysts And Casdozokitug HCC Drug Development
Coherus Oncology (CHRS) Reports Q2 Loss, Misses Revenue Estimates
Coherus Oncology: Setting Up For Important Readouts In Mid-2026 (NASDAQ:CHRS)
Coherus Oncology (CHRS) Reports Q1 Loss, Lags Revenue Estimates
Are Medical Stocks Lagging AnaptysBio (ANAB) This Year?
Is Brookdale Senior Living (BKD) Outperforming Other Medical Stocks This Year?
Coherus Oncology (CHRS) Upgraded to Buy: Here's What You Should Know
Is Biodesix (BDSX) Stock Outpacing Its Medical Peers This Year?
Coherus BioSciences at The Citizens Conference: Strategic Oncology Shift
Oppenheimer reiterates Coherus Biosciences stock rating at Outperform
Coherus Oncology, Inc. (CHRS) Q4 2025 Earnings Call Transcript
Coherus Oncology (CHRS) Reports Q4 Loss, Misses Revenue Estimates